GT Biopharma, Inc. (GTBP)
NASDAQ: GTBP · Real-Time Price · USD
0.6195
+0.0660 (11.92%)
At close: Nov 7, 2025, 4:00 PM EST
0.5976
-0.0219 (-3.54%)
After-hours: Nov 7, 2025, 7:28 PM EST
GTBP's stock price has decreased by -79.28% in the past year and price targets may not have had time to catch up.
GT Biopharma Analyst Ratings
Total Analysts
1
Consensus Rating
Strong Buy
Price Target
$11.00
Upside
+1,675.63%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Roth MKM | Roth MKM | Strong Buy Initiates $11 | Strong Buy | Initiates | $11 | +1,675.63% | Dec 2, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $150 | Strong Buy | Reiterates | $150 | +24,113.08% | Aug 8, 2023 |
| EF Hutton | EF Hutton | Hold Reiterates $60 | Hold | Reiterates | $60 | +9,585.23% | Aug 7, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $150 | Strong Buy | Reiterates | $150 | +24,113.08% | Jun 5, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $150 | Strong Buy | Reiterates | $150 | +24,113.08% | May 17, 2023 |
| EF Hutton | EF Hutton | Hold Reiterates $60 | Hold | Reiterates | $60 | +9,585.23% | May 16, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $150 | Strong Buy | Reiterates | $150 | +24,113.08% | Apr 3, 2023 |
| EF Hutton | EF Hutton | Hold Reiterates $60 | Hold | Reiterates | $60 | +9,585.23% | Mar 31, 2023 |
| EF Hutton | EF Hutton | Hold Initiates $60 | Hold | Initiates | $60 | +9,585.23% | Jan 5, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $750 → $150 | Strong Buy | Maintains | $750 → $150 | +24,113.08% | Sep 13, 2022 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $750 | Strong Buy | Initiates | $750 | +120,965.38% | May 24, 2021 |
| Roth Capital | Roth Capital | Strong Buy Initiates $750 | Strong Buy | Initiates | $750 | +120,965.38% | Mar 17, 2021 |